A Prospective Multicenter Randomized Controlled Trial of Flexible And Navigable Suction Ureteral Access Sheath Combined With Needle Perc for the Treatment of Partial Staghorn Renal Calculi
NCT ID: NCT06914986
Last Updated: 2025-04-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
344 participants
INTERVENTIONAL
2025-04-01
2028-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Does flexible and navigable suction ureteral access sheath combined with needle perc result in similar stone free rate compared with PCNL
* Does flexible and navigable suction ureteral access sheath combined with needle perc result in more complications compared with PCNL Researchers will compare flexible and navigable suction ureteral access sheath combined with needle perc result in similar stone free rate compared with PCNL to see if flexible and navigable suction ureteral access sheath combined with needle perc works to treat partial staghorn renal calculi.
Participants will:
* Performed flexible and navigable suction ureteral access sheath combined with needle perc or PCNL
* Visit the clinic after surgery 1 month and 3 month for checkups and tests
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety and Effectiveness of Antegrade Flexible Ureteroscopy-Assisted Percutaneous Nephrolithotomy for Staghorn Calculi
NCT07172373
Ureteroscopy Combined With Negative Pressure Sheath Treatment of Kidney Stones
NCT06938113
Comparison of Total Tubeless Mini-PCNL Versus Tubeless Mini-PCNL
NCT06288022
Efficacy and Safety of Flexible Ureteroscopy Versus Percutaneous Nephrolithotomy in Management of Staghorn Stones
NCT07322471
FANS-Assisted Mini-PCNL for Complex Renal Stones
NCT07332286
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
flexible and navigable suction ureteral access sheath combined with needle perc
Performed flexible and navigable suction ureteral access sheath combined with needle perc
Patients are performed flexible and navigable suction ureteral access sheath combined with needle perc or PCNL
PCNL group
PCNL
Patients were performed flexible and navigable suction ureteral access sheath combined with needle perc or PCNL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Performed flexible and navigable suction ureteral access sheath combined with needle perc
Patients are performed flexible and navigable suction ureteral access sheath combined with needle perc or PCNL
PCNL
Patients were performed flexible and navigable suction ureteral access sheath combined with needle perc or PCNL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. CT scan indicates partial staghorn calculi
3. Able to complete the study in accordance with the protocol requirements
4. Informed about the study and has signed the informed consent form
Exclusion Criteria
2. Significant calyceal hydronephrosis (calyceal width ≥ 2 cm)
3. Renal stone volume \> 33.5 cm³
4. Renal stones or nephrocalcinosis caused by genetic diseases or definite metabolic disorders that have not been ruled out, such as renal tubular acidosis, primary hyperoxaluria, primary hyperparathyroidism, etc.
5. Congenital or structural renal abnormalities: spinal deformity, ankylosing spondylitis, horseshoe kidney, medullary sponge kidney, duplicated kidney, polycystic kidney, ectopic kidney, etc.
6. History of previous open renal stone surgery
7. Patients with uncontrolled urinary tract infections
8. Subjects deemed by the investigator to have other factors that make them unsuitable for participation in this trial
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beijing Tsinghua Chang Gung Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
24747-0-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.